Literature DB >> 19852581

Early events of secondary degeneration after partial optic nerve transection: an immunohistochemical study.

Melinda Fitzgerald1, Carole A Bartlett, Alan R Harvey, Sarah A Dunlop.   

Abstract

Secondary degeneration in the central nervous system involves indirect damage to neurons and glia away from the initial injury. Partial transection of the dorsal optic nerve (ON) results in precise spatial separation of the primary trauma from delayed degenerative events in ventrally placed axons and parent somata. Here we conduct an immunohistochemical survey of secondary cellular changes in and around axons and their parent retinal ganglion cell (RGC) somata during the first 3 days after a restricted, dorsal ON transection. This is before the secondary loss of RGCs and axons projecting through the uninjured, ventral portion of the ON. Within 5 min, manganese superoxide dismutase (MnSOD; a marker of oxidative stress) co-localizes within the astrocytic network across the entire profile of the ON. Secondary astrocyte hypertrophy of immunofluorescent labeling was evident from 3 h, with sustained increases in myelin basic protein immunoreactivity across the nerve by 24 h. Increases in NG-2-positive oligodendrocyte precursor cells, ED-1-positive activated microglia/macrophages, and Iba1-positive reactive resident microglia/macrophage numbers were only seen in ON vulnerable to secondary degeneration by 3 days. Changes within RGC somata exclusively vulnerable to secondary degeneration were detected at 24 h, as evidenced by increases in MnSOD immunoreactivity, followed by increases in c-jun immunoreactivity at 3 days. Treatment with the voltage-gated calcium channel blocker lomerizine did not alter any measured outcome. We conclude that oxidative stress spreading via the astrocytic network and from injured axons to parent RGC somata is an early event during secondary degeneration, and containment is likely to be required in order to prevent further damage to the nerve.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19852581     DOI: 10.1089/neu.2009.1112

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  46 in total

Review 1.  BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Authors:  Margaret E Maes; Cassandra L Schlamp; Robert W Nickells
Journal:  Prog Retin Eye Res       Date:  2017-01-04       Impact factor: 21.198

2.  Oligodendroglia Are Particularly Vulnerable to Oxidative Damage after Neurotrauma In Vivo.

Authors:  Marcus K Giacci; Carole A Bartlett; Nicole M Smith; K Swaminathan Iyer; Lillian M Toomey; Haibo Jiang; Paul Guagliardo; Matt R Kilburn; Melinda Fitzgerald
Journal:  J Neurosci       Date:  2018-06-18       Impact factor: 6.167

3.  Repeated mild traumatic brain injury in female rats increases lipid peroxidation in neurons.

Authors:  Nathanael J Yates; Stephen Lydiard; Brooke Fehily; Gillian Weir; Aaron Chin; Carole A Bartlett; Jacqueline Alderson; Melinda Fitzgerald
Journal:  Exp Brain Res       Date:  2017-04-17       Impact factor: 1.972

4.  Diffuse traumatic axonal injury in the optic nerve does not elicit retinal ganglion cell loss.

Authors:  Jiaqiong Wang; Michael A Fox; John T Povlishock
Journal:  J Neuropathol Exp Neurol       Date:  2013-08       Impact factor: 3.685

5.  Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma.

Authors:  Melissa L Cooper; Samuel D Crish; Denise M Inman; Philip J Horner; David J Calkins
Journal:  Exp Eye Res       Date:  2015-12-02       Impact factor: 3.467

6.  Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection.

Authors:  Lillian M Toomey; Carole A Bartlett; Maimuna Majimbi; Gopana Gopalasingam; Jennifer Rodger; Melinda Fitzgerald
Journal:  Exp Brain Res       Date:  2018-10-26       Impact factor: 1.972

7.  Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment.

Authors:  Mine Bariş; Gülgün Tezel
Journal:  Curr Ophthalmol Rep       Date:  2019-04-23

Review 8.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

9.  Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.

Authors:  Roberta Brambilla; Galina Dvoriantchikova; David Barakat; Dmitry Ivanov; John R Bethea; Valery I Shestopalov
Journal:  J Neuroinflammation       Date:  2012-09-10       Impact factor: 8.322

10.  Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens.

Authors:  Stephanie C Joachim; Oliver W Gramlich; Panagiotis Laspas; Heiko Schmid; Sabine Beck; Harald D von Pein; H Burkhard Dick; Norbert Pfeiffer; Franz H Grus
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.